MAISON DE FORMULATION

The Copper Peptide Everyone Is Talking About Has Been Studied Since 1973. Why GHK-Cu Is the Next Big Thing in Skincare

Skincare has a habit of rediscovering old ingredients. A molecule appears on social media, searches rise, brands begin building products around it, and suddenly something that has existed for decades is presented as the industry’s newest breakthrough.

Copper peptides are having that moment. But GHK-Cu is unusual because its scientific history stretches back more than half a century. The peptide was first isolated from human plasma in 1973, and subsequent research has explored its relationship with tissue repair, collagen, elastin and other components of the extracellular matrix. That makes GHK-Cu interesting for a reason that has very little to do with trends.

 

What exactly is GHK-Cu?

GHK is a naturally occurring tripeptide composed of three amino acids: glycine, histidine and lysine. When it binds copper, it forms GHK-Cu, commonly identified in cosmetic formulations as Copper Tripeptide-1. GHK has been detected naturally in human plasma, saliva and urine.

Its relationship with copper is particularly interesting because copper participates in biological processes involved in tissue repair and extracellular-matrix formation. Rather than thinking of GHK-Cu simply as an ingredient that “adds collagen,” it may be more useful to think about it as a signaling peptide that has been studied for its role in processes associated with repair and remodeling.

That distinction matters because skin isn’t a static material that we simply fill with collagen. It is living tissue governed by interconnected signaling systems, enzymes, structural proteins, lipids and inflammatory processes.

Why researchers became interested in it. The story begins with researcher Loren Pickart, who first isolated GHK from human plasma in 1973. What followed was decades of investigation into the peptide and its copper complex, including research into wound healing, tissue remodeling, collagen and elastin production.

Laboratory research has reported effects on fibroblast activity and extracellular-matrix components including collagen, elastin and glycosaminoglycans—the molecules involved in many of the characteristics we associate with resilient, hydrated and structurally supported skin.

Laboratory findings, however, only tell us so much. For skincare, the more important question is what happens when copper-peptide formulations are actually applied to human skin.

What does the human research show?

A number of human studies have investigated topical copper-peptide formulations. One study reported reductions in measured wrinkle volume and wrinkle depth following treatment with GHK-Cu. Another 12-week study involving 71 women reported improvements in fine lines and firmness measured through instrumental methods.

Other research has looked beyond what can be seen on the surface. A small three-month study involving 21 participants reported an average increase in collagen density of approximately 28% using ultrasound imaging, although individual responses varied considerably.

There is also older comparative research examining a copper-binding peptide cream alongside vitamin C, melatonin and tretinoin. In that study, increased procollagen synthesis was observed in a greater proportion of participants using the copper-peptide formulation than those using tretinoin.

That is an intriguing result, but it should not be translated into the much broader claim that copper peptides are “better than tretinoin.” The formulations, endpoints and evidence bases are different, and tretinoin has considerably more clinical research supporting its use for photoaging. One study can tell us something interesting without answering every question.

Fifty years of research doesn’t mean fifty years of perfect evidence

This is an important distinction because “50 years of research” can sound more definitive than the evidence actually is. GHK-Cu has an unusually long scientific history for a cosmetic peptide, but that does not mean there are dozens of large, modern dermatological trials establishing exactly what every topical GHK-Cu formulation will do.

Several of the frequently cited human studies are relatively small, some are decades old, and some findings come from industry-associated research. Those limitations are worth acknowledging rather than hiding, particularly in a category where the words “clinically proven” are often used far more broadly than the evidence warrants.

What is notable is that scientific interest in the molecule has continued. As of 2026, a Phase 2 randomized, double-blind study evaluating topical GHK-Cu for wound healing was listed as enrolling, extending a research story that began in the 1970s.

The part skincare marketing often leaves out

There is another problem with ingredient-led skincare: finding a biologically interesting molecule is not the same thing as creating an effective finished formulation. Seeing Copper Tripeptide-1 on an ingredient list tells you that the ingredient is present, but not necessarily how central it is to the formula or how the finished product will perform.

Concentration matters, but so do stability, delivery, compatibility with other ingredients and the overall vehicle. Even percentages can be misleading because formulators frequently purchase peptide complexes or solutions containing only a fraction of the named active. A formula containing 1% of a peptide raw material does not necessarily contain 1% pure peptide.

More importantly, skin aging doesn’t occur through one biological pathway. Changes in collagen occur alongside changes in barrier lipids, hydration, oxidative stress, inflammatory signaling, cellular communication and extracellular-matrix organization. An impressive ingredient can therefore be only one part of a much larger formulation strategy.

This is why we think the more interesting question in skincare is becoming less about which hero ingredient a product contains and more about how the entire formula has been constructed.

Why we formulate with GHK-Cu differently

When we developed LAMELLARE™ Structural Lipid Crème, we didn’t want copper peptide to carry the entire structural-aging story. GHK-Cu is incorporated as part of a broader peptide architecture that also includes Hexapeptide-11 and Palmitoyl Tripeptide-38, with GHK-Cu supplied through two different peptide systems.

Together, the three peptide-containing supplier complexes account for 3.74% of the finished formulation. That does not mean LAMELLARE contains 3.74% pure peptides, the distinction matters, but it does mean the formula was intentionally constructed around multiple peptide systems rather than the presence of a single hero peptide.

The peptides, in turn, sit within a much larger barrier-supportive architecture. LAMELLARE combines them with ceramides NP, AP and EOP, cholesterol, more than 5% panthenol, sodium PCA, saccharide isomerate, squalane and lipid-rich botanical oils and emollients.

The philosophy isn’t that more peptides automatically make better skincare. It’s that ingredients addressing different aspects of skin function can be combined intentionally rather than expecting one molecule to do everything.

Perhaps GHK-Cu tells us something bigger about where skincare is going

For decades, beauty innovation has frequently been organized around the hero ingredient. Vitamin C. Retinol. Hyaluronic acid. Peptides. Exosomes. Whatever molecule comes next. There is enormous commercial power in this model because a single ingredient is easy to communicate and easy for consumers to remember.

Biology is less convenient. Dryness, barrier dysfunction, oxidative stress, pigmentation, inflammation and structural aging don’t operate independently from one another. If the biology is interconnected, there is a strong argument that sophisticated formulation should be interconnected as well.

Perhaps the next generation of skincare innovation, then, won’t be defined solely by discovering another miracle molecule. We already have an extraordinary library of biologically interesting ingredients with decades of research behind many of them. The opportunity may increasingly lie in understanding how to combine them intelligently, at meaningful concentrations, through appropriate delivery systems, while maintaining the integrity of the skin barrier.

GHK-Cu is a fascinating example. Not because copper peptides suddenly became fashionable, but because this tiny three-amino-acid signal has been investigated for more than 50 years, and we’re still learning what it may be capable of.

That may ultimately be more interesting than any trend.

One Response

  1. Excellent article really love my product just started using it. I already see a difference in the texture of my skin. I bought the big package. I don’t remember the name of that legendary anyway it was $830 or something. I love it. Love it, love it want to add an eye cream, and know if you guys have any kind of tinted face cream.

    Reply

Leave a Reply

Your email address will not be published. Required fields are marked *

Join Waitlist

We will inform you when the product arrives in stock.
Please leave your valid email address below.